Labco: Innovation in Prenatal Biomedicine
As I introduced on my last post, our most recent commercial launch is a blood test for non-invasive prenatal testing, a test that can assess risk for Down Syndrome or trisomies 18 and 13 with no risk for the mother or baby. This opens a new window to prenatal testing, and represents probably the biggest advance in obstetrics in the history of medicine. But this is not intended to be a scientific publication, or at least not what I should be writing on. And I...
read moreEntrepreneurship and Passion in Healthcare
Through this series of posts I will be writing for Opinno once a month, I will try to provide a broad view of what I understand are the keys for being a successful entrepreneur in biomedicine. In fact, my own experience -of over ten years now- can be an interesting example for all those wishing to pursue their dream and make a living from their “super idea” related to healthcare. I always like to remember how I found myself initially immersed in this world...
read more





